Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
02:50
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
FAQs
   
Discussion forum - BSH 2020 VIRTUAL
    Topic - Thrombosis and Haemostasis

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Factor VIII levels and bleeding according to factor 8 mutation in pregnant carriers of haemophilia A: a multi-centre retrospective cohort study  Annie Collins 1      11/9/2020 12:01:00 PM  
External Quality Assurance (EQA) for the Thromboelastometry devices: UK NEQAS BC programme update  Dianne Kitchen 1      11/9/2020 12:01:00 PM  
Monitoring direct oral anticoagulant plasma concentrations experience from the Princess Royal University Hospital  Rachna Patel 1      11/9/2020 12:01:00 PM  
Utility of Pro C Global assay and Factor VIII activity as anti-coagulant and pro-coagulant factors in Hepatitis C cirrhotic patients  Ahmed Almenshawy 1      11/9/2020 12:01:00 PM  
The CAVEaT multicentre audit of venous thrombosis in patients with haematolical malignancy and thrombocytopenia: preliminary results.  Stephen Booth 1      11/9/2020 12:01:00 PM  
A retrospective review of suspected thrombotic thrombocytopenic purpura cases from a tertiary referral centre  Amy Knott 1      11/9/2020 12:01:00 PM  
Patients with below knee DVT are at risk of both under and over- treatment: results from a retrospective review of cases identified at University Hospitals Bristol  S K 1      11/9/2020 12:01:00 PM  
ISTH SSC plasma standard lot 5 results in a UK National External Quality Assessment Scheme for Blood Coagulation exercise  Ian Jennings 1      11/9/2020 12:01:00 PM  
Platelet storage pool disease with excessive bleeding associated with a novel FLI1 variant.  PATRICIA BIGNELL 1      11/9/2020 12:01:00 PM  
Venous Thromboembolism in a large teaching hospital over the last 10 years: changing patterns of disease  Huw Rowswell 1      11/9/2020 12:01:00 PM  
Overview of Clinical characteristics of patients with TTP (Thrombotic Thrombocytopenic Purpura) in a low socio-economic population in New York: A 6-year center experience.  Preethi Ramachandran 1      11/9/2020 12:01:00 PM  
Pre - analytical variables in haemostasis: Results of the UK National External Quality Assessment Scheme for Blood Coagulation haemolysis supplementary exercise.  Lilia Brown 1      11/9/2020 12:01:00 PM  
Investigation of von Willebrand factor polymorphisms in congenital Thrombotic Thrombocytopenic Purpura  Chiara Lupo 1      11/9/2020 12:01:00 PM  
A Systematic Review and Meta- Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Ovarian Cancer Receiving Chemotherapy  Thomas Erblich 1      11/9/2020 12:01:00 PM  
Approach to manage thrombotic events while on Anti coagulation  Lovina Thomas 1      11/9/2020 12:01:00 PM  
Discrepant interpretation of HIT screening results on the same sample - data from a UK NEQAS for Blood Coagulation exercise.  Ian Jennings 1      11/9/2020 12:01:00 PM  
Clinical Outcomes from Lupus Anticoagulant Testing  ARIELA HOXHA 1      11/9/2020 12:01:00 PM  
A Systematic Review of Efficacy and Safety of Chemical Thromboprophylaxis in Renal Transplantation  Ruchika Kohli 1      11/9/2020 12:01:00 PM  
Direct Oral Anticoagulants the real story of their side effect profile  Tara Maisel 1      11/9/2020 12:01:00 PM  
Bone And Joint Health Markers In Persons With Haemophilia A (PwHA) Treated With Emicizumab In HAVEN 3  Anna Kiialainen 1      11/9/2020 12:01:00 PM  
Fixed dose prothrombin complex concentrate for direct oral anticoagulant and warfarin reversal: a rapid and effective solution  Jennifer Davies 1      11/9/2020 12:01:00 PM  
Heparin-induced thrombocytopaenia (HIT): an audit of the diagnostic pathway at Barts Health NHS Trust  Martin Haywood 1      11/9/2020 12:01:00 PM  
The differential surface expression of tissue factor between monocyte subsets  Kathryn Musgrave 1      11/9/2020 12:01:00 PM  
Patients with acute Thrombotic Thrombocytopenic Purpura (TTP) should be managed in a Critical Care Setting A Single TTP Referral Centre Experience  Rebecca Shaw 1      11/9/2020 12:01:00 PM  
Comparing Patient Experience and Adherence with Rivaroxaban or Warfarin (PACT); Well, you know it (warfarin) kills rats, whats it doing to me?  Dan Sly 1      11/9/2020 12:01:00 PM  
Effects of Rivaroxaban on thrombophilia screening tests results from a UK NEQAS (Blood Coagulation) Exercise  Ian Jennings 1      11/9/2020 12:01:00 PM  
Do patients taking Direct Oral Anticoagulants (DOAC) require regular systematic review? Evidence from a Comprehensive Anticoagulation and Thrombosis Centre  Nicolas Martinez-Calle 1      11/9/2020 12:01:00 PM  
Shear flow-based assay with HUVECs shows von Willebrand Factor (VWF) strings anchored to the endothelial surface and platelet aggregation in acute immune-mediated Thrombotic Thrombocytopenic Purpura.  Chiara Vendramin 1      11/9/2020 12:01:00 PM  
Anticoagulation In Palliative And End Of Life Care - Results Of A Supra-Regional Audit And Literature Review  Kat Moss 1      11/9/2020 12:01:00 PM  
UK NEQAS for Blood Coagulation D-dimer Point of care testing programme  Dianne Kitchen 1      11/9/2020 12:01:00 PM  
Clinical Characteristics and Outcomes in Patients Treated with Eculizumab for Suspected Atypical Haemolytic Uraemic Syndrome (aHUS) - A Single Tertiary Centre Experience  Matthew Alley 1      11/9/2020 12:01:00 PM  
Why do we use warfarin today? A retrospective study from a large comprehensive anticoagulation centre.  Kumari Perera 1      11/9/2020 12:01:00 PM  
Outpatient Management of Pulmonary Embolism over Ten Years in a large teaching hospital: Safe and Evolving practice.  Huw Rowswell 1      11/9/2020 12:01:00 PM  
Observational study of outcomes in patients with antiphospholipid syndrome anticoagulated with Rivaroxaban  Thomas Erblich 1      11/9/2020 12:01:00 PM  
Management of pregnancy-associated acquired haemophilia A: a case-series from the Oxford Haemophilia and Thrombosis Centre, UK  Ayesha Ejaz 1      11/9/2020 12:01:00 PM  
Investigation of von Willebrand factor polymorphisms in congenital Thrombotic Thrombocytopenic Purpura  Chiara Lupo 1      11/3/2020  
Outpatient Management of Pulmonary Embolism over Ten Years in a large teaching hospital: Safe and Evolving practice.  Huw Rowswell 1      11/2/2020 6:27:00 PM  
Direct Oral Anticoagulants the real story of their side effect profile  Tara Maisel 1      11/1/2020 9:48:00 PM  
Utility of Pro C Global assay and Factor VIII activity as anti-coagulant and pro-coagulant factors in Hepatitis C cirrhotic patients  Ahmed Almenshawy 1      10/31/2020 11:38:00 PM  
       




Most viewed poster for this congress
Poster: 1
Visits: 407
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre: 

Poster most viewed in this topic
Poster: 165
Visits: 78
Title: Shear flow-based assay with HUVECs shows von Willebrand Factor (VWF) strings anchored to the endothelial surface and platelet aggregation in acute immune-mediated Thrombotic Thrombocytopenic Purpura.
Authors: Chiara Vendramin , Francesca Patella: MRC Laboratory for Molecular Cell Biology, UCL, London, UK; Chiara Lupo: Haemostasis Research Unit, UCL, London; Daniel Cutler: MRC Laboratory for Molecular Cell Biology, UCL, London, UK; Marie Scully: Haematology Department, UCLH, London, UK
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert